Table 6.
Comparison of treatment outcome, based on an immediate NPV ratio of 80%, between groups 1 and 2
| Treatment outcome | Group 1 | Group 2 | ||||
|---|---|---|---|---|---|---|
| ≥80% (n = 12) |
<80% (n = 5) |
P value | ≥80% (n = 40) |
<80% (n = 6) |
P value | |
| Fibroid volumea | ||||||
| Baseline | 0.208 | 0.765 | ||||
| Mean ± SD | 214.9 ± 200.0 | 94.2 ± 33.7 | 171.3 ± 137.0 | 152.7 ± 173.6 | ||
| Range | 37.0–794.0 | 51.0–143.0 | 6.0–637.0 | 12.0–478.0 | ||
| 6 months | 0.925 | 0.057 | ||||
| Mean ± SD | 88.8 ± 79.8 | 85.2 ± 36.2 | 83.1 ± 71.0 | 167.5 ± 215.1 | ||
| Range | 11.0–295.0 | 41.0–140.0 | 4.0–400.0 | 10.0–578.0 | ||
| Reduction ratio (6 months) | 0.001* | 0.001* | ||||
| Mean ± SD | 0.6 ± 0.15 | 0.11 ± 0.11 | 0.49 ± 0.13 | 0.03 ± 0.16 | ||
| Range | 0.25–0.8 | −0.03–0.2 | 0.22–0.84 | −0.21–0.18 | ||
| Symptom severity scoreb | ||||||
| Baseline | 0.916 | 0.155 | ||||
| Mean ± SD | 54.7 ± 14.4 | 55.6 ± 21.0 | 51.6 ± 16.1 | 62.0 ± 17.7 | ||
| Range | 31.2–75.0 | 31.2–87.5 | 21.9–84.4 | 43.7–93.7 | ||
| 6 months | 0.001* | 0.001* | ||||
| Mean ± SD | 4.2 ± 5.0 | 46.2 ± 16.9 | 6.2 ± 7.5 | 47.9 ± 31.8 | ||
| Range | 0.0–15.6 | 18.7–62.5 | 0.0–37.5 | 6.2–100.0 | ||
| Improvement ratio (6 months) | 0.001* | 0.001* | ||||
| Mean ± SD | 0.93 ± 0.8 | 0.15 ± 0.27 | 0.88 ± 0.14 | 0.25 ± 0.36 | ||
| Range | 0.75–1.0 | −0.2–0.43 | 0.5–1.0 | −0.07–0.89 | ||
SD standard deviation
aLargest treated fibroid only
bTransformed symptom severe score (SSS) can range from 0 to 100
*Statistically significant